PSIVIDA CORP. (PVA)
The Company is the successor entity to pSivida Limited (ASX code: PVA), an ASX listed pharmaceutical and biotechnology development company which undertook a restructure by way of scheme of arrangement resulting in it becoming a wholly owned subsidiary of the Company, thereby re-domiciling to the USA.On this page you will find:
|
Company snapshot Delayed share price Company announcements Price history chart Exchange Traded Options |
|
Company details Closing prices Dividends Warrants & Structured Products ASX CFDs |
Delayed share price
Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.
| Code | Last | % Chg | Bid | Offer | Open | High | Low | Vol |
|---|---|---|---|---|---|---|---|---|
| PVA | 3.040 | 1.33% | 2.810 | 3.090 | 3.000 | 3.040 | 3.000 | 380 |
ASX Find a broker tool
Helps you find an ASX broker based on your needs and where you live.
PSIVIDA CORP. details
Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.
| Issuer Code | PVA |
|---|---|
| Securities | |
| Official Listing Date | 12 June, 2008 |
| GICS Industry Group | Pharmaceuticals, Biotechnology & Life Sciences |
| Exempt Foreign? | No |
| Internet Address | http://www.psivida.com |
| Registered Office Address | c/- Blake Dawson, Level 37, 101 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000 |
| Head Office Telephone | (08) 9227 8327 |
| Head Office Fax | (08) 9227 6838 |
| Share Registry | COMPUTERSHARE INVESTOR SERVICES PTY LIMITED LEVEL 2, RESERVE BANK BUILDING, 45 ST GEORGES TERRACE, PERTH, WA, AUSTRALIA, 6000 |
| Share Registry Telephone | 1300 787 272 |
| Directors / Senior Management |
|---|
|
Dr David Mazzo (Non Exec. Chairman) Dr Paul Ashton (President, Managing Director, CEO) Mr Douglas Godshall (Director) Mr Paul Hopper (Director) Mr Michael Rogers (Director) Mr Peter Savas (Director) Mr Len Ross (Finance Director) Ms Lori Freedman (General Counsel) Mr Brian Leedman (Investor Relations) Mr Charles Baird (Local Agent) |
| Company Secretary |
Ms Lori Freedman |
|---|---|
| Principal Activities | The Company is the successor entity to pSivida Limited (ASX code: PVA), an ASX listed pharmaceutical and biotechnology development company which undertook a restructure by way of scheme of arrangement resulting in it becoming a wholly owned subsidiary of the Company, thereby re-domiciling to the USA. |
PSIVIDA CORP. announcements
How are company announcements published on www.asx.com.au?
| Date | Price sens. |
Headline | Pages | |
|---|---|---|---|---|
| 15/05/2013 | Form 10-Q | 29 | ||
| 14/05/2013 |
|
pSivida Corp. third quarter fiscal year 2013 results | 5 | |
| 08/05/2013 |
|
pSivida's Iluvien launches in Germany- first patient treated | 2 | |
| 07/05/2013 | pSivida announces third qtr financial results release date | 1 | ||
| 02/05/2013 | Appendix 3B | 13 | ||
| 02/05/2013 |
|
pSivida Announces New ILUVIEN PDUFA Date of October 17, 2013 | 3 | |
| 30/04/2013 |
|
pSivida reports that Iluvien is now available in the UK | 3 | |
| 11/04/2013 | pSivida launches new online corporate communications channel | 2 | ||
| 05/04/2013 |
|
pSivida announces new evaluation agreement with large Pharma | 2 | |
| 02/04/2013 | Appendix 3B | 13 |
> search for past company announcements
Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.
Closing prices
Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.
| Date | Last | % Change | High | Low | Vol * |
|---|---|---|---|---|---|
| 24 May 2013 | 3.040 | 1.33% | 3.040 | 3.000 | 380 |
| 23 May 2013 | 3.000 | 2.74% | 3.000 | 2.950 | 12,450 |
| 22 May 2013 | 2.920 | 2.46% | 2.920 | 2.920 | 6,300 |
| 21 May 2013 | 2.850 | -1.04% | 2.880 | 2.850 | 3,792 |
| 20 May 2013 | 2.880 | -7.1% | 2.880 | 2.880 | 3,303 |
* Volume of shares shown represents only those shares traded on ASX.
PSIVIDA CORP. price history chart

Dividends
How are dividends released on www.asx.com.au?
No dividends have been found for the security PVA. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.
Exchange Traded Options
No Exchange Traded Options are available over the security PVA
Warrants & Structured Products
No warrants & Structured Products are available over the security PVA
ASX CFDs
No Contracts For Differences are available over the security PVA

